16 participants
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-08
- Start Date:
- 2021-08-13
- Completion:
- 2023-11-21
Conditions
- Pancreatic Cancer
- Cancer of the Pancreas
- Pancreas Cancer
Interventions
- DRUG
- PROCEDURE